Assessment of topoisomerase II-alpha gene status by dual color chromogenic in situ hybridization in a set of Iraqi patients with invasive breast carcinoma
Background: The human epidermal growth factor receptor 2(HER2) proto-oncogene is overexpressed or amplified in approximately 15%–25% of invasive breast cancers. Approximately 35% of HER2-amplified breast cancers have coamplification of the topoisomerase II-alpha (TOP2A) gene encoding an enzyme that...
Main Authors: | Rasha Abd Alraouf Neama, Manal A Habib, Sahira A Ali, Ali H Al-Khafaji, Mohammed F Alqanbar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=4;spage=475;epage=480;aulast=Neama |
Similar Items
-
HER 2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
by: Hemlata S Shirsat, et al.
Published: (2012-01-01) -
Relationship SaRelationship Study Of The Verified H Uman Epidermal Growth Factor Receptor 2 Amplification With Other Tumor Markers And Clinicohistopathological Characteristics In Patients With Invasive Breast Cancer, Using Chromogenic In Situ Hybridizationtudy Of The Verified Human Epidermal Growth Factor Receptor 2 Amplification With Other Tumor Markers And Clinicohistopathological Characteristics In Patients With Invasive Breast Cancer, Using Chromogenic In Situ Hybridization
by: Abdolazim Sarli, et al.
Published: (2019-06-01) -
Chromogenic Technologies for Energy Saving
by: Alessandro Cannavale
Published: (2020-11-01) -
Synthesis of novel naphthoquinone-spermidine conjugates and their effects on DNA-topoisomerases I and II-alpha
by: Cunha Andréa S., et al.
Published: (2006-01-01) -
Evaluation of chromogenic media and seminested PCR in the identification of Candida species
by: Enas Daef, et al.
Published: (2014-01-01)